Howard Thom

Academic , Associate Professor in Health Economic Modelling and Evidence Synthesis

University of Bristol

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Howard Thom is an Associate Professor in Health Economic Modelling and Evidence Synthesis at The University of Bristol, UK. His research focuses on health economic modeling, particularly in the areas of treatment effectiveness and cost-effectiveness analysis in various clinical contexts. Recent publications include studies on survival outcomes using advanced statistical methods and systematic reviews of treatment comparisons in conditions such as renal cell carcinoma and alopecia areata.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (3)

Tony Ades

University of Bristol

UNITED KINGDOM

View details

Simon Shohet

UNITED KINGDOM

View details

David Aceituno

King's College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Howard Thom

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Treatment recommendations based on network meta-analysis: Rules for risk-averse decision-makers

Treatment recommendations based on network meta-analysis

Matching plus regression adjustment for the estimation of the average treatment effect on survival outcomes

Unanchored simulated treatment comparison on survival outcomes using parametric and Royston-Parmar models with application to lenvatinib plus pembrolizumab in renal cell carcinoma

Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease: a network meta-analysis utilizing patient-level and aggregate data

Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata

Point-of-care tests for urinary tract infections to reduce antimicrobial resistance: a systematic review and conceptual economic model

Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease

Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis

Long-Term Cost-Effectiveness of Case Finding and Mass Screening for Celiac Disease in Children

Collaborators (3)

Tony Ades

Simon Shohet

David Aceituno

Make your next move.